Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: lwd who wrote (5482)	8/17/1998 11:29:00 AM
From: aknahow	Read Replies (1) \| Respond to of 9719

If the DuPont rumors are true it will speed up the redeployment of funds to the drug/biotechnology sector. Also sale of DuPonts medical device unit to Stryker for $1.9 billion represents an exit from this area so perhaps medical device companies will not be on its' shopping list if and when it redeploys funds. nytimes.com Even if Sonofi is included as part of the deal with ELF, cash should be in excess of $15 billion, out of the $24 billion being mentioned. This is my estimate. Any better estimate will be appreciated.